Discovery of potent, non-peptide thrombin receptor antagonists.

被引：0

作者：

Chackalamannil, S

Xia, Y

Clasby, M

Greenlee, W

Doller, D

Eagen, K

Tsai, HS

Asberom, T

Lin, Y

Czarniecki, M

Ahn, HS

Foster, C

Boykow, G

机构：

[1] Schering Plough Res Inst, CNS Chem Res, CV, Kenilworth, NJ 07033 USA

[2] Schering Plough Res Inst, CNS Pharmacol, CV, Kenilworth, NJ 07033 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

342-MEDI

引用

页码：U60 / U60

页数：1

共 50 条

[21] De novo design of potent non-peptide thrombin inhibitors
Bohm, HJ
Banner, DW
Weber, L
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U689 - U689
[22] Structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as potent, non-peptide interleukine-8-receptor antagonists.
Li, JJ
Yue, WS
Trivedi, BK
Miller, SR
Connor, DT
Roth, BD
Low, JE
Hellig, DJ
Yang, WX
Qin, SX
Hunt, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U562 - U562
[23] Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
Su, DS
Markowitz, MK
DiPardo, RM
Murphy, KL
Harrell, CM
O'Malley, SS
Ransom, RW
Chang, RS
Ha, S
Hess, FJ
Pettibone, DJ
Mason, GS
Boyce, S
Freidinger, RM
Bock, MG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U38 - U38
[24] Non-peptide αvβ3 antagonists.: Part 4:: Potent and orally bioavailable chain-shortened RGD mimetics
Coleman, PJ
Askew, BC
Hutchinson, JH
Whitman, DB
Perkins, JJ
Hartman, GD
Rodan, GA
Leu, CT
Prueksaritanont, T
Fernandez-Metzler, C
Merkle, KM
Lynch, R
Lynch, JJ
Rodan, SB
Duggan, ME
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (17) : 2463 - 2465
[25] Advances in antihypertensive therapy: Non-peptide angiotensin II receptor antagonists as potent therapeutic agents
Smith, J
Wahhab, A
Hondrelis, J
Ganter, R
Moore, D
Matsoukas, JM
Moore, GJ
LETTERS IN PEPTIDE SCIENCE, 1996, 3 (04): : 169 - 174
[26] Structural requirements of non-peptide neurotensin receptor antagonists
Quere, L
Boigegrain, R
Jeanjean, F
Gully, D
Evrard, G
Durant, F
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1996, (12): : 2639 - 2646
[27] Automated parallel solid-phase synthesis of novel non-peptide CCR1 receptor antagonists.
Buckman, BO
Ghannam, A
Li, A
Liang, M
Mohan, R
Ng, HP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U661 - U661
[28] The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. Part 1
Veale, CA
Alford, VC
Aharony, D
Banville, DL
Bialecki, RA
Brown, FJ
Damewood, JR
Dantzman, CL
Edwards, PD
Jacobs, RT
Mauger, RC
Murphy, MM
Palmer, WE
Pine, KK
Rumsey, WL
Garcia-Davenport, LE
Shaw, A
Steelman, GB
Surian, JM
Vacek, EP
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (17) : 1949 - 1952
[29] Design, synthesis, and activity of a new class of chain-shortened non-peptide αvβ3 receptor antagonists.
Coleman, P
Askew, BC
Brashear, KM
Duggan, ME
Halczenko, W
Hartman, GH
Hutchinson, JH
Hunt, CA
Meissner, RS
Perkins, JJ
Whitman, D
Duong, LT
Leu, CT
Nagy, RM
Rodan, GA
Rodan, SB
Fernandez-Metzler, C
Merkle, K
Preksaritanont, T
Lynch, JL
Stump, G
Wallace, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U671 - U671
[30] Discovery and optimization of potent nonpeptidic glucagon antagonists.
Ladouceur, G
Cook, J
Doherty, E
Jones, H
Hertzog, D
Hundertmark, T
Korpusik, M
Lease, T
Livingston, J
MacDougall, M
Osterhout, M
Phelan, K
Romero, R
Shao, C
Schoen, W
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U973 - U973

← 1 2 3 4 5 →